Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | RORC | P51449 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL310122 | 0.98 | CHRM2 (0.41) | CHRM2CHRM1ALDH1A1POLBKDM4E | |
| SCHEMBL1061900 | 0.94 | CHRM2 (0.34) | CHRM2CHRM1ALDH1A1HTTKMT2A | |
| SCHEMBL1662667 | 0.94 | CHRM2 (0.34) | CHRM2CHRM1ALDH1A1HTTKMT2A | |
| SCHEMBL64211 | 0.92 | CHRM2 (0.47) | CHRM2CHRM1ALDH1A1POLBKDM4E | |
| SCHEMBL3178617 | 0.90 | CHRM2 (0.46) | CHRM2CHRM1ALDH1A1POLBKDM4E | |
| SCHEMBL22345800 | 0.90 | CHRM2 (0.46) | CHRM2CHRM1ALDH1A1POLBKDM4E | |
| SCHEMBL1803635 | 0.86 | CHRM2 (0.43) | CHRM2CHRM1ALDH1A1POLBKDM4E | |
| Isopropyl Alcohol SCHEMBL7567318 | 0.85 | KMT2A (0.41) | CHRM2CHRM1ALDH1A1POLBKDM4E | |
| SCHEMBL1827043 | 0.83 | CHRM2 (0.41) | CHRM2CHRM1ALDH1A1POLBKDM4E | |
| SCHEMBL2417 | 0.83 | ALDH1A1 (0.45) | CHRM2CHRM1ALDH1A1KDM4EHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 367 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118317947-A | Sortilin inhibitors | 索蒂纳制药股份有限公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-118265710-A | Pyridine compounds as KV7.2 enhancers | 伊卡根有限责任公司 | 2024-06-28 | — | — | CN | disclosed |
| CN-111183151-B | Purification of subspecies of factor VIII | 武田药品工业株式会社 | 2024-06-07 | — | — | CN | disclosed |
| CN-111989400-B | Alpha-amylase, compositions and methods | 丹尼斯科美国公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-118043041-A | LPAR1 antagonists and uses thereof | 康蒂内乌姆医疗公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-118043044-A | Allosteric ketene inhibitors of phosphoinositide 3-kinase (PI 3K) for the treatment of disease | 佩特拉制药公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-117940406-A | MAP4K1 inhibitors | 缆图药品公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-117940438-A | Heterocyclic compounds as MAP4K1 inhibitors | 缆图药品公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-117769546-A | Allosteric ketene inhibitors of phosphoinositide 3-kinase (PI 3K) for the treatment of disease | 佩特拉制药公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-110777132-B | Alpha-amylase combination variants | 丹尼斯科美国公司 | 2024-03-22 | — | — | CN | disclosed |
| EP-0865419-A1 | INDANE DIMER COMPOUNDS AND THEIR PHARMACEUTICAL USE | Venantius Limited (IE) | 1998-09-23 | — | — | EP | disclosed |
| WO-1997020802-A1 | INDANE DIMER COMPOUNDS AND THEIR PHARMACEUTICAL USE | VENANTIUS LIMITED (IE) | 1997-06-12 | — | — | WO | disclosed |
| US-5262650-A | Viewer system and method for fluorescence evaluation | DENTSPLY VENTURE CAPITAL ASSOCIATES, L.P. (US) | 1993-11-16 | — | — | US | disclosed |
| WO-1992021771-A1 | EPIDERMAL GROWTH FACTOR RECEPTOR ECTODOMAIN | TRITON DIAGNOSTICS, INC. (US) | 1992-12-10 | — | — | WO | disclosed |
| EP-0480207-A2 | Test system viewer for fluorescence evaluation | DENTSPLY VENTURE CAPITAL ASSOCIATES L.P. (US) | 1992-04-15 | — | — | EP | disclosed |
| EP-0480208-A2 | Test system timer | DENTSPLY VENTURE CAPITAL ASSOCIATES L.P. (US) | 1992-04-15 | — | — | EP | disclosed |
| EP-0463004-A4 | METABOLIC EFFECTS OF LEUKAEMIA INHIBITORY FACTOR ON BONE | — | 1992-04-01 | — | — | EP | disclosed |
| US-5089709-A | TEST SYSTEM VIEWER FOR FLUORESCENCE EVALUATION | DENTSPLY VENTURE CAPITAL ASSOCIATES, L.P. (US) | 1992-02-18 | — | — | US | disclosed |
| EP-0463004-A1 | METABOLIC EFFECTS OF LEUKAEMIA INHIBITORY FACTOR ON BONE | AMRAD CORPORATION LIMITED (AU) | 1992-01-02 | — | — | EP | disclosed |
| WO-1990010454-A1 | METABOLIC EFFECTS OF LEUKAEMIA INHIBITORY FACTOR ON BONE | AMRAD CORPORATION LIMITED (AU) | 1990-09-20 | — | — | WO | disclosed |